Lazard UK Omega Fund C IncRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -5.7 | 15.0 | -2.4 | 10.9 | 5.6 | |
+/-Cat | 3.4 | -3.0 | -0.4 | 2.7 | 0.2 | |
+/-B’mrk | - | - | - | 3.3 | -0.5 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 07/05/2024 | GBP 2.59 | |
Day Change | 0.73% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B87ZL660 | |
Fund Size (Mil) 07/05/2024 | GBP 43.04 | |
Share Class Size (Mil) 07/05/2024 | GBP 13.82 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.76% |
Investment Objective: Lazard UK Omega Fund C Inc |
The objective of the Sub-Fund is to achieve capital growth over at least 5 years. The Sub-Fund will invest at least 70% in equity and equity-related securities (namely, common and preferred stock, including securities subject to an initial public offering, convertible securities, warrants and rights) (“Securities”) of companies that are domiciled, incorporated, or which have a significant portion of their business primarily in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Aaron Barnfather 30/09/2023 | ||
Tomasz Bulinski 30/09/2023 | ||
Click here to see others | ||
Inception Date 01/11/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard UK Omega Fund C Inc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 7.26 |
Shell PLC | Energy | 6.46 |
HSBC Holdings PLC | Financial Services | 6.30 |
BP PLC | Energy | 6.15 |
Unilever PLC | Consumer Defensive | 6.06 |
Increase Decrease New since last portfolio | ||
Lazard UK Omega Fund C Inc |